Drugs

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Drugs
Mar 22, 2025, 13:05 | Drugs
Zeynep Irem Ozay: Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, shared an article she and her…
Mar 20, 2025, 08:31 | Drugs
Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An analysis from the LEO Consortium
Recently an article Jonathan R. Day and colleagues authored was published at blood advances. Treatment patterns…
Mar 18, 2025, 12:43 | Drugs
Oliver Maracic: Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer LGSOC
Oliver Maracic, Investor, shared a post on LinkedIn: "Avutometinib + Defactinib in Recurrent Low-Grade Serous…
Mar 14, 2025, 15:22 | Drugs
Enfortumab Vedotin (Padcev): What Patients Need To Know?
Enfortumab vedotin, also known as Padcev, is a groundbreaking antibody-drug conjugate (ADC) designed to treat…
Mar 14, 2025, 13:13 | Drugs
Enfortumab Vedotin (Padcev): Uses in Cancer, Side Effects, Dosage, Expectations, and More
Enfortumab Vedotin, also known as Padcev, is a groundbreaking antibody-drug conjugate (ADC) designed to target…
Mar 12, 2025, 11:00 | Drugs
Relatlimab : What Patients Need To Know?
Relatlimab is a novel immunotherapy drug developed by Bristol Myers Squibb (BMS) that targets the…
Mar 11, 2025, 10:08 | Drugs
Relatlimab: Novel LAG-3 Immunotherapy uses in Cancer, Side Effects, Dosages, Expectations, and More
Relatlimab, a human monoclonal antibody targeting LAG-3 (lymphocyte activation gene-3), is an innovative checkpoint inhibitor…
Mar 11, 2025, 09:56 | Drugs
Raffaele Colombo: Sacituzumab tirumotecan was approved for a second indication by NMPA in China
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X: "Sacituzumab tirumotecan approved…
Mar 11, 2025, 08:03 | Drugs
Naveen Pemmaraju: Bromodomain and PLX51107 with Azacitidine in Patients with R/R Myeloid Malignancies
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University…
Mar 6, 2025, 12:21 | Drugs
Zolbetuximab: Uses in Cancer, Side Effects, Dosages, Expectations, and More
Zolbetuximab is a monoclonal antibody that targets Claudin 18.2 (CLDN18.2), a tight-junction protein that is…
All: 493 Posts: 11 - 20
Special Coverage